These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9787333)

  • 1. Acute reversible arthropathy in a pediatric patient with cancer treated with a short course of ciprofloxacin for febrile neutropenia.
    Mullen CA; Petropoulos D; Rytting M; Jeha S; Zipf T; Roberts WM; Rolston KV
    J Pediatr Hematol Oncol; 1998; 20(5):516-7. PubMed ID: 9787333
    [No Abstract]   [Full Text] [Related]  

  • 2. Ciprofloxacin in children: is arthropathy a limitation?
    Singh UK; Sinha RK; Prasad B; Chakrabarti B; Sharma SK
    Indian J Pediatr; 2000 May; 67(5):386-7. PubMed ID: 10885214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin use: acute arthropathy and long-term follow up.
    Karande S; Kshirsagar NA
    Indian Pediatr; 1996 Nov; 33(11):910-6. PubMed ID: 9141825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones.
    Warren RW
    Pediatr Infect Dis J; 1997 Jan; 16(1):118-22; discussion 123-6. PubMed ID: 9002121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-benefit experience of ciprofloxacin use in pediatric patients in the United Kingdom.
    Redmond AO
    Pediatr Infect Dis J; 1997 Jan; 16(1):147-9; discussion 160-2. PubMed ID: 9002126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis.
    Salam MA; Dhar U; Khan WA; Bennish ML
    Lancet; 1998 Aug; 352(9127):522-7. PubMed ID: 9716056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
    Peacock JE; Herrington DA; Wade JC; Lazarus HM; Reed MD; Sinclair JW; Haverstock DC; Kowalsky SF; Hurd DD; Cushing DA; Harman CP; Donowitz GR
    Ann Intern Med; 2002 Jul; 137(2):77-87. PubMed ID: 12118962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients.
    Freifeld A; Pizzo P
    Pediatr Infect Dis J; 1997 Jan; 16(1):140-5; discussion 145-6, 160-2. PubMed ID: 9002125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential quinolone-induced cartilage toxicity in children.
    Camp KA; Miyagi SL; Schroeder DJ
    Ann Pharmacother; 1994 Mar; 28(3):336-8. PubMed ID: 8193422
    [No Abstract]   [Full Text] [Related]  

  • 10. Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient.
    Samuelson WM; Pleasants RA; Whitaker MS
    Ann Pharmacother; 1993 Mar; 27(3):302-3. PubMed ID: 8453165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-exposure anthrax prophylaxis.
    Med Lett Drugs Ther; 2001 Oct; 43(1116-1117):91-2. PubMed ID: 11689760
    [No Abstract]   [Full Text] [Related]  

  • 12. A new ciprofloxacin stepdown program in the treatment of high-risk febrile neutropenia: a clinical and economic analysis.
    Marra CA; Frighetto L; Quaia CB; de Lemos ML; Warkentin DI; Marra F; Jewesson PJ
    Pharmacotherapy; 2000 Aug; 20(8):931-40. PubMed ID: 10939554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summaries for patients. Treatment of fever in hospitalized patients with low white blood cell counts.
    Ann Intern Med; 2002 Jul; 137(2):I20. PubMed ID: 12118984
    [No Abstract]   [Full Text] [Related]  

  • 14. Ciprofloxacin safety in a pediatric population.
    Jick S
    Pediatr Infect Dis J; 1997 Jan; 16(1):130-3; discussion 133-4, 160-2. PubMed ID: 9002123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate.
    Sipsas NV; Kosmas C; Ziakas PD; Karabelis A; Vadiaka M; Skopelitis E; Kordossis T; Tsavaris N
    Scand J Infect Dis; 2007; 39(9):786-91. PubMed ID: 17701717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis].
    Postnikov SS
    Antibiot Khimioter; 2001; 46(3):16-20. PubMed ID: 11548276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin as a therapeutic modality in pediatric burn wound infections: efficacious or contraindicated?
    Heggers JP; Villarreal C; Edgar P; Wolf S; Klein GL; John SD; Desai M; Herndon DN
    Arch Surg; 1998 Nov; 133(11):1247-50. PubMed ID: 9820358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
    Aquino VM; Herrera L; Sandler ES; Buchanan GR
    Cancer; 2000 Apr; 88(7):1710-4. PubMed ID: 10738231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute psychosis in a trauma patient due to ciprofloxacin.
    James EA; Demian AZ
    Postgrad Med J; 1998 Mar; 74(869):189-90. PubMed ID: 9640454
    [No Abstract]   [Full Text] [Related]  

  • 20. Nightmare due to ciprofloxacin in young patients.
    Dey SK
    Indian Pediatr; 1995 Aug; 32(8):918-20. PubMed ID: 8635840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.